“Rexsan Pharmaceuticals’ strategic goal is in line with its core value of developing pharmaceutical solutions that restore, renew and regulate key processes in the human body for optimal human well-being.
To this end, we pursue a strategy of providing consumers with products that meet high standards of efficacy, quality and safety. This obliges us to take into account individual patient reactions to medicines and to ensure that the efficacy and safety of our products are monitored.
To this end, the company has set up a pharmacovigilance system aimed at collecting and analysing data on the side-effects of its products, identifying their causes and adjusting technologies and processes to minimise adverse effects and prevent their occurrence in future.
You can report an adverse reaction to pharmaceuticals in the following ways:
by writing to us: info@rexsanpharma.lt
by directly filling in the form online in the Information System for Medicinal Products of the State Medicines Control Authority under the Ministry of Health of the Republic of Lithuania https://vapris.vvkt.lt/vvkt-web/public/nrv
by completing the Patient Report of Suspected Adverse Reaction (PRA) form available at https://www.vvkt.lt/index.php?4004286486 and sending it by e-mail (to NepageidaujamaR@vvkt.lt)
by calling free 8 800 73 568.
We would be very grateful if you could provide us with information about possible adverse effects of our products. We will ensure that the information you provide is kept confidential and used only in accordance with legal requirements.
